Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Composition Comprising Glucoraphanin, Myrosinase and a Buffered Solution for Use in the Treatment of Neurodegenerative Diseases

NCT07360977 is registered in ClinicalTrials.gov with IRCCS Centro Neurolesi Bonino Pulejo as lead sponsor.

NCT NCT07360977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07360977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Composition Comprising Glucoraphanin, Myrosinase and a Buffered Solution for Use in the Treatment of Neurodegenerative Diseases
Lead sponsor
IRCCS Centro Neurolesi Bonino Pulejo
Phase
Not applicable
Overall status
Recruiting
Start date
January 31, 2026
Completion date
May 19, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms) - relapsing-remitting, parkinson disease (disorder), pediatric patients affected by neuromuscolar and degenerative diseases